- Home
- DJCO vs DNA Comparison
DJCO vs DNA Comparison
Compare DJCO & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DJCO
- DNA
- Stock Information
- Founded
- DJCO 1987
- DNA 2008
- Country
- DJCO United States
- DNA United States
- Employees
- DJCO N/A
- DNA N/A
- Industry
- DJCO Newspapers/Magazines
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DJCO Consumer Discretionary
- DNA Health Care
- Exchange
- DJCO Nasdaq
- DNA Nasdaq
- Market Cap
- DJCO 569.1M
- DNA 658.5M
- IPO Year
- DJCO N/A
- DNA N/A
- Fundamental
- Price
- DJCO $389.45
- DNA $11.07
- Analyst Decision
- DJCO
- DNA Sell
- Analyst Count
- DJCO 0
- DNA 3
- Target Price
- DJCO N/A
- DNA $9.67
- AVG Volume (30 Days)
- DJCO 87.7K
- DNA 1.6M
- Earning Date
- DJCO 08-13-2025
- DNA 08-07-2025
- Dividend Yield
- DJCO N/A
- DNA N/A
- EPS Growth
- DJCO 375.38
- DNA N/A
- EPS
- DJCO 76.72
- DNA N/A
- Revenue
- DJCO $73,247,000.00
- DNA $237,417,000.00
- Revenue This Year
- DJCO N/A
- DNA N/A
- Revenue Next Year
- DJCO N/A
- DNA $15.81
- P/E Ratio
- DJCO $5.24
- DNA N/A
- Revenue Growth
- DJCO 1.99
- DNA 13.76
- 52 Week Low
- DJCO $359.34
- DNA $5.00
- 52 Week High
- DJCO $602.00
- DNA $16.85
- Technical
- Relative Strength Index (RSI)
- DJCO 39.47
- DNA 61.33
- Support Level
- DJCO $418.00
- DNA $8.21
- Resistance Level
- DJCO $443.50
- DNA $13.33
- Average True Range (ATR)
- DJCO 14.47
- DNA 0.91
- MACD
- DJCO -2.39
- DNA 0.14
- Stochastic Oscillator
- DJCO 3.38
- DNA 55.86
About DJCO Daily Journal Corp. (S.C.)
Daily Journal Corp publishes newspapers and websites covering California and Arizona and produces several specialized information services. The company operates in two segments: Traditional business and Journal Technologies which includes Journal Technologies, Inc. and Journal Technologies (Canada) Inc. It also serves as a newspaper representative specializing in public notice advertising. The majority of revenue is generated from the Traditional segment.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.